| FTHFX | MOORX | FTHFX / MOORX | |
| Total Expense Ratio | 0.63 | 1.10 | 57% |
| Annual Report Gross Expense Ratio | 0.63 | 1.11 | 57% |
| Fund Existence | 14 years | 12 years | - |
| Gain YTD | 13.694 | 0.664 | 2,063% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 11.1B | 517M | 2,147% |
| Annual Yield % from dividends | 0.69 | 0.23 | 294% |
| Returns for 1 year | 11.63 | -1.13 | -1,033% |
| Returns for 3 years | 50.29 | 16.59 | 303% |
| Returns for 5 years | 75.57 | 6.15 | 1,228% |
| Returns for 10 years | 225.13 | 33.27 | 677% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UBRL | 23.33 | 0.14 | +0.62% |
| GraniteShares 2x Long UBER Daily ETF | |||
| BDBT | 25.61 | 0.09 | +0.35% |
| Bluemonte Core Bond ETF | |||
| XBIL | 50.21 | 0.02 | +0.04% |
| F/m US Treasury 6 Month Bill ETF | |||
| VXX | 26.97 | -0.09 | -0.33% |
| iPath® B S&P 500® VIX S/T Futs™ ETN | |||
| FMED | 27.46 | -0.15 | -0.54% |
| Fidelity Disruptive Medicine ETF | |||